Edition:
United Kingdom

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

11.20USD
16 Oct 2018
Change (% chg)

$0.51 (+4.77%)
Prev Close
$10.69
Open
$11.05
Day's High
$11.43
Day's Low
$10.52
Volume
654,706
Avg. Vol
326,812
52-wk High
$19.80
52-wk Low
$6.60

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 4.58
Market Cap(Mil.): $552.43
Shares Outstanding(Mil.): 70.37
Dividend: --
Yield (%): --

Financials

  IOVA.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -2.11 -- --
ROI: -49.36 0.73 14.32
ROE: -80.46 1.82 16.04

Earnings vs. Estimates